1. Abstract 1.1. Background: In Phase-2 COVID-19 pandemic, timely control of new outbreaks is pivotal to avoid an epidemic rebound. A better knowledge of clinical disease profiles and the development of sensitive diagnostic flow charts will help to take more effectiveactions. 1.2. Patients and Methods: We studied an outbreak occurred in 3 families during a …
Total Hip Arthroplasty (THA) in patients with hepatitis C virus (HCV) are known for poor outcomes increased risk of iatrogenic infection. New Direct Antiviral Agents (DAA) can now cure HCV infection. However, undertreatment is still common in patients undergoing THA. Our aim was to assess the prevalence of HCV infection and treatment rates inpatients with …
Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty Read More »
Chronic Liver Disease (CLD) is caused by several agents and leads to mortality through various mechanisms. Several prognostic factors have been discussed for CLD. Follistatin (FST) is a potential marker for liver function, muscle function, and metabolism. We evaluated whether FST correlated with prognosis and clinical factors
Controversial results have been reported about the progression of liver disease in HIV-HCV coinfected populations. The purpose of this study is to assess long-term liver disease progression in a group of coinfected patients with hemophilia
Emergence of Hepatitis B Surface Antigen (HBsAg) in a patient with previously negative Hepatitis B Virus (HBV) serology post Orthotropic Liver Transplant (OTLX) is known as De-novo Hepatitis B (DNHB). To study the clinical profile and epidemiology of patients with DNHB in Qatar. This descriptive epidemiological study was done by retrospectively reviewing records of 159 …
Drug-induced liver injury (DILI) is a serious issue faced by the pharmaceutical industry, and often leads to drug withdrawal once patients experience drug-induced severe hepatic failure. We developed an in vitro assay system that enables to assess cellular damage and immune reaction responses that ultimately result in DILI using troglitazone as a model drug….
To study the application of adjuvant chemotherapy in the treatment of Perihilar cholangiocarcinoma (pCCA). We retrospectively collected the data of 86 patients who underwent surgery for perihilar cholangiocarcinoma in our department between 2012 to 2017. The patients were divided into surgery alone group (n=44) and adjuvant….
To explore the variables which could predict the prognosis and might be considered as staging factors in patients with T2N0M0 Esophageal Squamous Cell Carcinoma (ESCC).Records of 525 patients with pathologic T2N0M0 ESCC who underwent surgical resection were reviewed. The T2 category was further subdivided into T2a (circular muscle layers) and T2b (longitudinal muscle layers)….
Postoperative pancreatitis complications can be separated into two main groups based on literature reviews and clinical trials. Some authors suggest that postoperative pancreatitis is a severe complication that should be treated conservatively and operatively if needed. Other authors defend an opposite opinion that only postoperative hyperamylasemia exists, which is a transitory condition with no risk …
The symptoms of asthma and gastroesophageal reflux disease are similar making it difficult to distinguish. Diagnosing Gastroesophageal Reflux Disease (GERD) is complex, as it frequently presents with other pulmonary disease or conditions. Asthma has often been associated with gastroesophageal reflux disease…
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.